We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Pre-Shaped Guidewire Sized for Smaller Ventricles

By HospiMedica International staff writers
Posted on 03 Aug 2015
Print article
The Boston Scientific Safari2 pre-shaped guidewire
The Boston Scientific Safari2 pre-shaped guidewire (Photo courtesy of Boston Scientfic )
An enhanced version of the Safari guidewire facilitates the introduction and placement of interventional devices within the heart.

The Boston Scientific Safari2 pre-shaped guidewire is designed to offer streamlined device delivery with enhanced wire predictability and shape retention for placing interventional devices within the heart, including those used with transcatheter aortic valve implantation or replacement procedures (TAVI/R). The Safari2 product line offers a wide choice with three curve sizes, including a new extra small curve designed for procedures involving patients with smaller ventricles. Prior to the Safari guidewire, physicians used peripheral intervention guidewires manually shaped for TAVI procedures.

The Safari2 Guidewire is designed to complement the Boston Scientific Lotus Valve System, a next-generation TAVI/R device designed to give physicians more control throughout the procedure. The Lotus Valve System offers an alternative treatment for patients with severe aortic stenosis who are at high risk for surgical valve replacement. The Safari and Safari2 guidewires and the Lotus Valve System are products of Boston Scientific (Natick, MA, USA), and have received the European Community CE marking of approval. They are distributed separately.

“The Safari2 Guidewire reflects our dedication and our commitment to meaningful innovation in the treatment of structural heart disorders,” said Tom Fleming, vice president and general manager of the structural heart division at Boston Scientific. “We will continue to invest in technologies like Safari2 which facilitate successful TAVI/R outcomes and improve quality of life for patients with valvular disease worldwide.”

“Having a pre-shaped, universal TAVR guidewire helps physicians deliver the replacement valve with reliability and consistency,” commented Wesley Pederson, MD, director of valve and structural heart disease at the Minneapolis Heart Institute Foundation (MHIF; MN, USA; www.mplsheart.org). “This is a wonderful development to have a smaller curve size so that we can offer this less invasive treatment option to a broader range of patients, because valvular disease can have a devastating impact on patient survival and quality of life.”

TAVI involves the percutaneous insertion of a catheter containing a replacement valve at a site in the groin or the left chest. The new valve is pushed into the correct site where the surgeon expands it and pushes the old one aside. The procedure is much less invasive than traditional open heart aortic valve replacement and does not require putting the patient on a heart and lung machine, so it can be performed on those who cannot have open heart surgery.

Related Links:

Boston Scientific 

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Portable Manual Defibrillator
Ultrasound System
HERA W10 Elite
Surgical Light
HyLED 600 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register



view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.